Patents

Draft Patents (Amendment), Rules, 2023

The Ministry of Commerce and Industry, under the Department for Promotion of Industry and Internal Trade, has introduced draft amendments to the Patents Rules, 2003. These drafts detail various changes proposed by the Central Government, anchored on section 159 of the Patents Act, 1970. The government seeks to amend the …

Free trade will bind India

30 agreements to be signed; they violate public interest say activists the seventh round of free trade negotiations between India and EU held at Brussels in mid-July ended in a deadlock after the negotiators disagreed on the modalities of the agreement. Fresh talks will be held in November to thresh …

Intellectual Property Rights: Excluding other rights of other people

This article interrogates the claims of intellectual property to be a right. Drawing on the political theory of rights, it argues that information, ideas and knowledge fail to meet the basic test of rights and intellectual property right prevents those who do not own it from accessing and exercising their …

Running out of patents, MNCs focus on animal healthcare

Animal healthcare in India is no longer an afterthought as global pharmaceutical companies facing loss in revenues due to expiring drug patents are looking for new growth markets. With many of their blockbuster drugs going off-patent in the coming months, pharma MNCs are looking to focus more on the animal …

Can Bill Gates tame hurricanes?

Bids For Patent On System For Lowering Ocean Temperatures To Slow Down Storms Tony Allen-Mills Bill Gates, the co-founder of Microsoft, is backing inventors and climate scientists who claim to have devised a technique for diminishing the power of hurricanes. Gates was named last week among a group of weather …

Novartis not ready to give up on Glivec

To Challenge Intellectual Property Appellate Board Verdict Rejecting Its Patent Plea For Cancer Drug Nina Mehta MUMBAI THE Indian subsidiary of Swiss drugmaker Novartis will challenge a decision by the Intellectual Property Appellate Board (IPAB) that said its cancer drug Glivec was not patentable. Addressing the company

Novartis loses battle for cancer drug patent

PB Jayakumar / Mumbai July 05, 2009, 0:03 IST Novartis

Evergreening A controversial issue in pharma milieu

A patent is an exclusive right awarded by the intellectual property (IP) authority of a state to an inventor or his assignee for a limited period of time in lieu of disclosure of an invention for the benefit of mankind. In recent times, it has become a practice by a …

News 360<sup></sup> - Briefs

patent Human genes create stir in US About 100,000 cancer patients, doctors, researchers and lawyers sued the US government for granting patents for two human genes. They said the patents deny women with breast and ovarian cancer the benefit of new tests and possible treatment. A company or an institution …

UNITAID, drug cos discuss patent pool

Khomba Singh NEW DELHI IN a move aimed to ensure supply of low-cost HIV drugs globally, UNITAID, an international facility for purchase of drugs against HIV/AIDS, malaria and tuberculosis (TB), held discussions with Indian generic drug makers on Tuesday to develop the world

New study on protecting drugs in India

A MAJOR new study identifying a broad range of potential benefits of incremental pharmaceutical innovation for India will be released at the US-India Business Council

India loses patents due to improper documentation

June 16: India is losing over 2,000 patents every year on traditional formulations as they were never properly documented, the Union minister for state and environment, Mr Jairam Ramesh, said here on Tuesday. The patent offices in the European Union and the US have now been given full access to …

Microbes can be patented

Mashelkar report says modified organisms are intellectual property THE expert group on patent law headed by R A Mashelkar has recommended that microbes like bacteria, fungi and virus should be patented if they have been modified. The committee has also said India cannot limit its patents to new chemical substances …

Make 'Flame' but don't sell it: SC to TVS

The Supreme Court today allowed Chennai-headquartered TVS Motor Co to manufacture

The value of incremental pharmaceutical innovation: benefits for Indian patients and Indian business

Improved quality of drug products in India, including products that are better suited to India

Innovation and technology transfer to address climate change

This paper examines issues surrounding the development and transfer of technologies for addressing the problem of climate change based on the experience of developing countries in addressing problems of innovation and access in the fi eld of medicines. It looks at alternative energy resources (AERs) and climate change mitigation technologies …

New diet regime for calves

Beneficial and cost effective, says cooperative that introduced feed a milk cooperative in Kolhapur district, Maharashtra, has bagged a patent on one of its products that cuts the cost of calf rearing by half. The cooperative, popularly called Gokul, after its brand of milk products, has launched two calf-rearing products: …

TVS Motor allowed to produce Flame

CHENNAI: A Division Bench of the Madras High Court has given TVS Motor Company the go-ahead for manufacturing and marketing the 125-cc Flame, according to a release from the company. The launch of Flame had triggered a legal between the company and Bajaj Auto, which had claimed that it had …

Pfizer to market off patent injectables with Claris

Leading pharmaceutical company Pfizer Inc has entered into a partnership with Ahmedabad-based Claris Lifesciences Ltd to commercialise sterile injectible drugs that are off-patent and have lost exclusivity in the United States, Canada, Australia, New Zealand and Europe. These drugs cover a range of therapeutic areas, including anti-infectives, antibiotics and other …

  1. 1
  2. ...
  3. 12
  4. 13
  5. 14
  6. 15
  7. 16
  8. ...
  9. 34

IEP child categories loading...